These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

581 related items for PubMed ID: 17295757

  • 21. Recent concepts in non-alcoholic fatty liver disease.
    Adams LA, Angulo P.
    Diabet Med; 2005 Sep; 22(9):1129-33. PubMed ID: 16108837
    [Abstract] [Full Text] [Related]

  • 22. Prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population.
    Dassanayake AS, Kasturiratne A, Rajindrajith S, Kalubowila U, Chakrawarthi S, De Silva AP, Makaya M, Mizoue T, Kato N, Wickremasinghe AR, de Silva HJ.
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1284-8. PubMed ID: 19476560
    [Abstract] [Full Text] [Related]

  • 23. High-fat diet: a trigger of non-alcoholic steatohepatitis? Preliminary findings in obese subjects.
    Vilar L, Oliveira CP, Faintuch J, Mello ES, Nogueira MA, Santos TE, Alves VA, Carrilho FJ.
    Nutrition; 2008 Jul; 24(11-12):1097-102. PubMed ID: 18640006
    [Abstract] [Full Text] [Related]

  • 24. Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome.
    Moore JB.
    Proc Nutr Soc; 2010 May; 69(2):211-20. PubMed ID: 20158939
    [Abstract] [Full Text] [Related]

  • 25. Prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non-alcoholic fatty liver disease.
    Wong VW, Hui AY, Tsang SW, Chan JL, Wong GL, Chan AW, So WY, Cheng AY, Tong PC, Chan FK, Sung JJ, Chan HL.
    Aliment Pharmacol Ther; 2006 Oct 15; 24(8):1215-22. PubMed ID: 17014580
    [Abstract] [Full Text] [Related]

  • 26. [Non alcoholic fatty liver. A frequent entity with an unknown outcome].
    Barisio D'Angelo MG, Mariel Actis A, Outomuro D.
    Rev Gastroenterol Peru; 2009 Oct 15; 29(1):44-50. PubMed ID: 19424408
    [Abstract] [Full Text] [Related]

  • 27. Nonalcoholic fatty liver disease and the metabolic syndrome.
    Marchesini G, Babini M.
    Minerva Cardioangiol; 2006 Apr 15; 54(2):229-39. PubMed ID: 16778754
    [Abstract] [Full Text] [Related]

  • 28. Nonalcoholic fatty liver disease: hepatic manifestation of obesity and the metabolic syndrome.
    Boppidi H, Daram SR.
    Postgrad Med; 2008 Jul 31; 120(2):E01-7. PubMed ID: 18654060
    [Abstract] [Full Text] [Related]

  • 29. Non-alcoholic fatty liver disease pathogenesis: the present and the future.
    Petta S, Muratore C, Craxì A.
    Dig Liver Dis; 2009 Sep 31; 41(9):615-25. PubMed ID: 19223251
    [Abstract] [Full Text] [Related]

  • 30. Interaction of metabolic syndrome, nonalcoholic fatty liver disease and chronic hepatitis C.
    Rafiq N, Younossi ZM.
    Expert Rev Gastroenterol Hepatol; 2008 Apr 31; 2(2):207-15. PubMed ID: 19072356
    [Abstract] [Full Text] [Related]

  • 31. Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis.
    Tsochatzis E, Papatheodoridis GV, Manesis EK, Kafiri G, Tiniakos DG, Archimandritis AJ.
    Aliment Pharmacol Ther; 2008 Jan 01; 27(1):80-9. PubMed ID: 17919273
    [Abstract] [Full Text] [Related]

  • 32. Epidemiology of non-alcoholic fatty liver disease in China.
    Fan JG, Farrell GC.
    J Hepatol; 2009 Jan 01; 50(1):204-10. PubMed ID: 19014878
    [Abstract] [Full Text] [Related]

  • 33. Histological assessment of non-alcoholic fatty liver disease.
    Hübscher SG.
    Histopathology; 2006 Nov 01; 49(5):450-65. PubMed ID: 17064291
    [Abstract] [Full Text] [Related]

  • 34. Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations.
    Preiss D, Sattar N.
    Clin Sci (Lond); 2008 Sep 01; 115(5):141-50. PubMed ID: 18662168
    [Abstract] [Full Text] [Related]

  • 35. Predictive factors for pure steatosis in alcoholic patients.
    Naveau S, Thaury J, Barri-Ova N, Balian A, Dauvois B, Njiké-Nakseu M, Prévot S, Agostini H, Perlemuter G.
    Alcohol Clin Exp Res; 2009 Jun 01; 33(6):1104-10. PubMed ID: 19382900
    [Abstract] [Full Text] [Related]

  • 36. Significant correlations between severe fatty liver and risk factors for metabolic syndrome.
    Hsiao PJ, Kuo KK, Shin SJ, Yang YH, Lin WY, Yang JF, Chiu CC, Chuang WL, Tsai TR, Yu ML.
    J Gastroenterol Hepatol; 2007 Dec 01; 22(12):2118-23. PubMed ID: 18031368
    [Abstract] [Full Text] [Related]

  • 37. Treatment of patients with non-alcoholic fatty liver disease: current views and perspectives.
    Federico A, Trappoliere M, Loguercio C.
    Dig Liver Dis; 2006 Nov 01; 38(11):789-801. PubMed ID: 16750661
    [Abstract] [Full Text] [Related]

  • 38. Non-alcoholic fatty liver disease.
    Leclercq I.
    Bull Mem Acad R Med Belg; 2010 Nov 01; 165(3-4):147-55; discussion 155-8. PubMed ID: 21166266
    [Abstract] [Full Text] [Related]

  • 39. Update on non-alcoholic fatty liver disease in children.
    Papandreou D, Rousso I, Mavromichalis I.
    Clin Nutr; 2007 Aug 01; 26(4):409-15. PubMed ID: 17449148
    [Abstract] [Full Text] [Related]

  • 40. [Alcoholic and nonalcoholic steatohepatitis: the same disease! I. Diagnosis and mechanisms].
    Spahr L, Rubbia-Brandt L, Hadengue A.
    Rev Med Suisse; 2005 Sep 07; 1(31):2026-8, 2030-1. PubMed ID: 16212004
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.